APT Medical Inc
SSE:688617
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
APT Medical Inc
Accounts Payable
APT Medical Inc
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
APT Medical Inc
SSE:688617
|
Accounts Payable
¥60.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
S
|
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
|
Accounts Payable
¥312.3m
|
CAGR 3-Years
36%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Accounts Payable
¥1.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
19%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Accounts Payable
¥3.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Accounts Payable
¥45.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
0%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Accounts Payable
¥2.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
APT Medical Inc
Glance View
APT Medical Inc. is a company embedded in the intricate world of medical devices, specializing in the development, production, and distribution of cardiovascular and peripheral vascular medical products. The company’s foundation rests on its ability to innovate and provide solutions that address the complex challenges faced by healthcare professionals in the treatment of heart and vascular diseases. APT Medical strategically focuses on minimally invasive technologies, which are increasingly preferred for their reduced patient recovery times and overall improvement in procedural success rates. By keeping its pulse on the evolving demands within the healthcare sector, APT Medical efficiently aligns its research and development initiatives to meet the global standards and expectations. Revenue streams for APT Medical Inc. flow primarily from its broad portfolio of interventional medical devices, such as guidewires, balloon catheters, and vascular closure devices. The intricacy of their manufacturing processes, coupled with stringent regulatory requirements, ensures that their offerings are both high in quality and competitively priced. Through a network of strategic partnerships, distribution channels, and a robust export framework, the company extends its reach across several international markets. By maintaining a keen focus on customer service and post-market support, APT Medical not only thrives on initial sales but also secures a steady stream of revenue from recurring purchases and long-term partnerships with healthcare institutions globally.
See Also
What is APT Medical Inc's Accounts Payable?
Accounts Payable
60.3m
CNY
Based on the financial report for Dec 31, 2025, APT Medical Inc's Accounts Payable amounts to 60.3m CNY.
What is APT Medical Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
48%
Over the last year, the Accounts Payable growth was 30%. The average annual Accounts Payable growth rates for APT Medical Inc have been 14% over the past three years , 48% over the past five years .